Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Platelet Activation in End-Stage Renal Disease Is Mediated By Extracellular Nucleosomes That Originate from White Blood Cells

Trung Phan, McMillan Ryan, Leonidas Skiadopoulos, Amanda Walborn, Debra Hoppensteadt, PhD, Vinod Bansal, Jawed Fareed, PhD

Blood (2016) 128 (22): 4909.

https://doi.org/10.1182/blood.V128.22.4909.4909

Published: 2016

Journal Articles

Upregulation of Microparticles, Tissue Factor, Adhesion Molecules, Nitric Oxide and Adiponectin in End Stage Renal Disease

Jawed Fareed, PhD DSC, FACB, Vinod Bansal, Daneyal Syed, Debra Hoppensteadt, PhD, Nil Guler, MD

Blood (2015) 126 (23): 2312.

https://doi.org/10.1182/blood.V126.23.2312.2312

Published: 2015

Journal Articles

Role of Platelet Activation in the Pathogenesis of Heart Failure in End-Stage Renal Disease Patients

Ryan McMillan, Vinod Bansal, Leonidas Skiadopoulos, Debra Hoppensteadt, PhD, Omer Iqbal, MD, Ravipresenna Parasuraman, Nil Guler, MD, Jawed Fareed, PhD

Blood (2015) 126 (23): 4636.

https://doi.org/10.1182/blood.V126.23.4636.4636

Published: 2015

Journal Articles

Increased Levels Of Tissue Factor, Adhesion Molecules, Nitric Oxide and Adiponectin In End Stage Renal Disease. A Complex Interplay

Jawed Fareed, Ph.D., Kristiyana Kaneva, Debra Hoppensteadt, Ph.D., Vinod Bansal, MD

Blood (2013) 122 (21): 4742.

https://doi.org/10.1182/blood.V122.21.4742.4742

Published: 2013

Journal Articles

Dysregulation Of Thrombotic and Hemostatic Factors In End Stage Renal Disease

Vinod Bansal, MD, Debra Hoppensteadt, Ph.D., Syed Ahmed, Jawed Fareed, Ph.D.

Blood (2013) 122 (21): 4793.

https://doi.org/10.1182/blood.V122.21.4793.4793

Published: 2013

Journal Articles

Defibrotide Interactions with Newer Oral Anticoagulants and Antithrombotic Agents

Jawed Fareed, PhD, Debra Hoppensteadt, Omer Iqbal, MD, Josephine Cunanan, MD, Vinod Bansal, MD, Schuharazad Abro, Rakesh Wahi, MD

Blood (2012) 120 (21): 3411.

https://doi.org/10.1182/blood.V120.21.3411.3411

Published: 2012

Journal Articles

Variations in the Circulating Heparin Levels During Maintenance Hemodialysis in End Stage Renal Disease Patients

Vinod Bansal, MD, Kristiyana Kaneva, Debra Hoppensteadt, Josephine Cunanan, MD, Jawed Fareed, PhD

Blood (2012) 120 (21): 3412.

https://doi.org/10.1182/blood.V120.21.3412.3412

Published: 2012

Journal Articles

Markers of Thrombogenesis Activation and Endothelial Dysfunction in End Stage Renal Disease

Vinod Bansal, MD, Korosh Sharain, Debra Hoppensteadt, Ph.D., Evangelos Litinas, MD, Bruce E Lewis, MD, Jawed Fareed, PhD

Blood (2011) 118 (21): 1151.

https://doi.org/10.1182/blood.V118.21.1151.1151

Published: 2011

Journal Articles

Molecular Mimicry in the Adulteration of Heparins. Chemical Basis for the Development of Oversulfated Chondroitin Sulfate and Related Contaminants

Jawed Fareed, PhD, Rakesh Wahi, MD, Indermohan Thethi, MD, Debra Hoppensteadt, Ph.D., Vinod Bansal, MD, Jeanine M. Walenga, PhD, Harry L. Messmore, MD

Blood (2011) 118 (21): 4322.

https://doi.org/10.1182/blood.V118.21.4322.4322

Published: 2011

Journal Articles

Prevalence of Heparin Induced Thrombocytopenia Antibodies During the Period 2004–2011. Relevance to Heparin Contaminants

Jawed Fareed, PhD, Cafer Adiguzel, MD, Debra Hoppensteadt, Ph.D., Walter Jeske, Ph.D., Jeanine M. Walenga, PhD, Bruce E Lewis, MD, Harry L. Messmore, Jr., MD, Vinod Bansal, MD

Blood (2011) 118 (21): 4326.

https://doi.org/10.1182/blood.V118.21.4326.4326

Published: 2011

Journal Articles

Activation Markers of Thrombogenesis and Endothelial Dysfunction In End-Stage Renal Disease

Korosh Sharain, Rachael Davis, Debra Hoppensteadt, Ph.D., Josephine Cunanan, MD, Evangelos Litinas, MD, Vinod Bansal, MD, Jawed Fareed, PhD

Blood (2010) 116 (21): 5183.

https://doi.org/10.1182/blood.V116.21.5183.5183

Published: 2010

Journal Articles

Biochip Array Profiling of Inflammatory Cytokines and Growth Factors In End-Stage Renal Disease: Hematological Implications?

Korosh Sharain, Debra Hoppensteadt, Ph.D., Josephine Cunanan, MD, Evangelos Litinas, MD, Vinod Bansal, MD, Jawed Fareed, PhD

Blood (2010) 116 (21): 5184.

https://doi.org/10.1182/blood.V116.21.5184.5184

Published: 2010

Journal Articles

Upregulation of Inflammatory Mediators In End-Stage Renal Disease as Measured Via Biochip Array Technology

Vinod Bansal, MD, Rachael Davis, Evangelos Litinas, MD, Debra Hoppensteadt, Ph.D., Indermohan Thethi, MD, Jawed Fareed, PhD

Blood (2010) 116 (21): 5186.

https://doi.org/10.1182/blood.V116.21.5186.5186

Published: 2010

Journal Articles

Differential Modulation of Cytokines by VEGF In End Stage Renal Disease

Vinod Bansal, MD, Debra Hoppensteadt, Ph.D., Evangelos Litinas, MD, Indermohan Thethi, MD, Jawed Fareed, PhD

Blood (2010) 116 (21): 5187.

https://doi.org/10.1182/blood.V116.21.5187.5187

Published: 2010

Journal Articles

Upregulation of Von Willebrand Factor, Von Wilelbrand Factor Propeptide, and ADMATS-13 In End-Stage Renal Disease

Jawed Fareed, PhD, Evangelos Litinas, MD, Debra Hoppensteadt, Professor, Indermohan Thethi, MD, Vinod Bansal, MD

Blood (2010) 116 (21): 5189.

https://doi.org/10.1182/blood.V116.21.5189.5189

Published: 2010

Journal Articles

Protease Generation by Chondroitin Sulfate, Semisynthetic OSCS Preparations and Contaminants Isolated From Heparin.

Melanie Clark, Nasir Sadeghi, Debra Hoppensteadt, Lauren Myers, Vinod Bansal, Eduardo Ramacciotti, M.D., Ph.D., Jawed Fareed

Blood (2009) 114 (22): 3133.

https://doi.org/10.1182/blood.V114.22.3133.3133

Published: 2009

Journal Articles

Contaminants Isolated From Recalled Heparin Are Not All the Same: Clinical Implications.

Jawed Fareed, Melanie Clark, Vinod Bansal, Lauren Myers, Omer Iqbal, MD, Debra Hoppensteadt, Eduardo Ramacciotti, M.D., Ph.D., Jeanine M. Walenga, PhD

Blood (2009) 114 (22): 1069.

https://doi.org/10.1182/blood.V114.22.1069.1069

Published: 2009

Journal Articles

A Higher Prevalence of HIT Antibodies in Patients May Be Due to Contaminated Heparin

Vinod Bansal, Josephine Cunanan, Cafer Adiguzel, Evangelos Litinas, Kelly Nelson, Jawed Fareed

Blood (2008) 112 (11): 3022.

https://doi.org/10.1182/blood.V112.11.3022.3022

Published: 2008

Journal Articles

Fibrinokinetic Deficit in Chronic Kidney Disease and End Stage Renal Disease Patients Contributes to the Hemostatic Abnormalities

Cafer Adiguzel, Vinod Bansal, Josephine Cunanan, Evangelos Litinas, Debra Hoppensteadt, Jawed Fareed

Blood (2008) 112 (11): 4078.

https://doi.org/10.1182/blood.V112.11.4078.4078

Published: 2008

Journal Articles

Increased Levels of Anaphylatoxin (C5a) and Bradykinin in End-Stage Renal Disease Patients on Maintenance Hemodialysis. Potential Relevance to Heparin Mediated Hemodynamic Responses

Cafer Adiguzel, Vinod Bansal, Josephine Cunanan, Evangelos Litinas, Debra Hoppensteadt, Jawed Fareed

Blood (2008) 112 (11): 4079.

https://doi.org/10.1182/blood.V112.11.4079.4079

Published: 2008

NARROW

Platelet Activation in End-Stage Renal Disease Is Mediated By Extracellular Nucleosomes That Originate from White Blood Cells

Upregulation of Microparticles, Tissue Factor, Adhesion Molecules, Nitric Oxide and Adiponectin in End Stage Renal Disease

Role of Platelet Activation in the Pathogenesis of Heart Failure in End-Stage Renal Disease Patients

Increased Levels Of Tissue Factor, Adhesion Molecules, Nitric Oxide and Adiponectin In End Stage Renal Disease. A Complex Interplay

Dysregulation Of Thrombotic and Hemostatic Factors In End Stage Renal Disease

Defibrotide Interactions with Newer Oral Anticoagulants and Antithrombotic Agents

Variations in the Circulating Heparin Levels During Maintenance Hemodialysis in End Stage Renal Disease Patients

Markers of Thrombogenesis Activation and Endothelial Dysfunction in End Stage Renal Disease

Molecular Mimicry in the Adulteration of Heparins. Chemical Basis for the Development of Oversulfated Chondroitin Sulfate and Related Contaminants

Prevalence of Heparin Induced Thrombocytopenia Antibodies During the Period 2004–2011. Relevance to Heparin Contaminants

Activation Markers of Thrombogenesis and Endothelial Dysfunction In End-Stage Renal Disease

Biochip Array Profiling of Inflammatory Cytokines and Growth Factors In End-Stage Renal Disease: Hematological Implications?

Upregulation of Inflammatory Mediators In End-Stage Renal Disease as Measured Via Biochip Array Technology

Differential Modulation of Cytokines by VEGF In End Stage Renal Disease

Upregulation of Von Willebrand Factor, Von Wilelbrand Factor Propeptide, and ADMATS-13 In End-Stage Renal Disease

Protease Generation by Chondroitin Sulfate, Semisynthetic OSCS Preparations and Contaminants Isolated From Heparin.

Contaminants Isolated From Recalled Heparin Are Not All the Same: Clinical Implications.

A Higher Prevalence of HIT Antibodies in Patients May Be Due to Contaminated Heparin

Fibrinokinetic Deficit in Chronic Kidney Disease and End Stage Renal Disease Patients Contributes to the Hemostatic Abnormalities

Increased Levels of Anaphylatoxin (C5a) and Bradykinin in End-Stage Renal Disease Patients on Maintenance Hemodialysis. Potential Relevance to Heparin Mediated Hemodynamic Responses

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only